Euroopa Liit - eesti - EMA (European Medicines Agency)

mylan ireland limited - rivaroksabaan - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombootilised ained - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - rivaroksabaan - acute coronary syndrome; coronary artery disease; peripheral arterial disease; venous thromboembolism; stroke; atrial fibrillation; pulmonary embolism - antitrombootilised ained - täiskasvanud patsientidel, kellele tehti plaaniline puusa- või põlveliigese asendamise operatsiooni venoosse trombemboolia (vte) ennetamine. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 haemodynamically ebastabiilne pe patsientidel). adultsprevention of stroke and systemic embolism in adult patients with non valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. rivaroxaban accord, co administered with acetylsalicylic acid (asa) alone or with asa plus ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers (see sections 4. 3, 4. 4 ja 5. rivaroxaban accord, co administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Eesti - eesti - Ravimiamet

g.l. pharma gmbh - rivaroksabaan - õhukese polümeerikattega tablett - 20mg 42tk; 20mg 5tk; 20mg 30tk; 20mg 100tk; 20mg 60tk; 20mg 10tk; 20mg 14tk; 20mg 45tk; 20mg 28tk; 20mg 90tk; 20mg 98tk

Eesti - eesti - Ravimiamet

g.l. pharma gmbh - rivaroksabaan - õhukese polümeerikattega tablett - 10mg 98tk; 10mg 28tk; 10mg 14tk; 10mg 45tk; 10mg 30tk; 10mg 90tk; 10mg 100tk; 10mg 5tk; 10mg 42tk; 10mg 60tk; 10mg 10tk

Eesti - eesti - Ravimiamet

g.l. pharma gmbh - rivaroksabaan - õhukese polümeerikattega tablett - 15mg 98tk; 15mg 56tk; 15mg 30tk; 15mg 45tk; 15mg 10tk; 15mg 42tk; 15mg 14tk; 15mg 5tk; 15mg 90tk; 15mg 60tk; 15mg 100tk

Eesti - eesti - Ravimiamet

teva b.v. - rivaroksabaan - õhukese polümeerikattega tablett - 20mg 28tk; 20mg 90tk; 20mg 112tk; 20mg 100tk; 20mg 200tk; 20mg 10tk; 20mg 14tk; 20mg 30tk; 20mg 98tk

Eesti - eesti - Ravimiamet

teva b.v. - rivaroksabaan - õhukese polümeerikattega tablett - 15mg 100tk; 15mg 90tk; 15mg 14tk; 15mg 28tk; 15mg 200tk; 15mg 42tk; 15mg 30tk; 15mg 10tk; 15mg 98tk; 15mg 112tk

Eesti - eesti - Ravimiamet

teva b.v. - rivaroksabaan - õhukese polümeerikattega tablett - 10mg 200tk; 10mg 98tk; 10mg 5tk; 10mg 10tk; 10mg 28tk; 10mg 30tk; 10mg 100tk; 10mg 90tk; 10mg 112tk

Eesti - eesti - Ravimiamet

auxilia pharma oÜ - rivaroksabaan - õhukese polümeerikattega tablett - 10mg 100tk; 10mg 90tk; 10mg 14tk; 10mg 28tk; 10mg 45tk; 10mg 30tk; 10mg 20tk; 10mg 50tk; 10mg 15tk; 10mg 42tk; 10mg 56tk; 10mg 10tk; 10mg 98tk; 10mg 5tk

Eesti - eesti - Ravimiamet

auxilia pharma oÜ - rivaroksabaan - õhukese polümeerikattega tablett - 15mg 14tk; 15mg 15tk; 15mg 98tk; 15mg 30tk; 15mg 28tk; 15mg 20tk; 15mg 5tk; 15mg 90tk; 15mg 50tk; 15mg 56tk; 15mg 45tk; 15mg 10tk; 15mg 42tk; 15mg 100tk